(Ajinomoto Bio-Pharma Services) Whitepaper: From Research to Commercial Quantities: A Seamless Supply of Oligonucleotides
As the development of oligonucleotide-based therapeutics continuities to grow, companies are facing multifaceted challenges in scaling up to meet commercial needs. In this white paper, Ajinomoto Bio-Pharma Services discusses various platforms to easily, quickly, and cost-effectively scale up custom oligonucleotides from research to commercial quantities.
(Biosearch Technologies) Whitepaper: The Versatility of PNA
Download the white paper from LGC, Biosearch Technologies to learn about the versatility of PNAs and how they have been used in a wide array of applications ranging from targeted gene therapy to gene expression to other molecular diagnostics.
(RiboBio) Whitepaper: Large Scale Manufacturing for Oligonucleotide API
RiboBio's new API cGMP facility will provide multiple kilograms scale of oligonucleotide manufacturing services for late phase programs and commercial drugs.
(Bio-Works) Video: ECP - A New Approach to Multistep Downstream Purification Strategies
Set-up of purification processes is often done by copy-paste or based on experience according to well-known dogma. We have together with customer found reasons to challenge these in the interest of improving overall purity and process cost.
In this video presentation we are introducing this thinking and giving some examples where it has proven effective.
(Bachem) Whitepaper: Biological Potency Assays for Synthetic Peptide API GMP Release
This whitepaper showcases our experience in responding to customer requests and/or regulatory requirements with biological potency assays for GMP release testing of synthetic peptide API. A case study highlights successful development and validation of one such assay, in the context of a CMO specializing in the manufacture of GMP Peptide and Oligonucleotide APIs, through strong partnership with our CRO.